112 related articles for article (PubMed ID: 9046079)
1. Iodolisuride and iodobenzamide, two ligands for SPECT exploration of the dopaminergic D2 receptors: a comparative study.
Pellevoisin C; Guilloteau D; Baulieu JL; Loc'h C; Dognon AM; Mauclaire L; Saccavini JC; Besnard JC; Chalon S
Synapse; 1996 Sep; 24(1):79-86. PubMed ID: 9046079
[TBL] [Abstract][Full Text] [Related]
2. Comparison of two radioiodinated ligands of dopamine D2 receptors in animal models: iodobenzamide and iodoethylspiperone.
Pellevoisin C; Chalon S; Zouakia A; Dognon AM; Frangin Y; Baulieu JL; Besnard JC; Guilloteau D
Life Sci; 1993; 52(23):1851-60. PubMed ID: 8502122
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of [123I]IBZM pinhole SPECT for the detection of striatal dopamine D2 receptor availability in rats.
Scherfler C; Scholz SW; Donnemiller E; Decristoforo C; Oberladstätter M; Stefanova N; Diederen E; Virgolini I; Poewe W; Wenning GK
Neuroimage; 2005 Feb; 24(3):822-31. PubMed ID: 15652317
[TBL] [Abstract][Full Text] [Related]
4. No direct correlation between behaviorally active doses of the dopamine D2 agonist LY 171555 and displacement of [123I]IBZM as measured with SPECT in MPTP monkeys.
Vermeulen RJ; Drukarch B; Verhoeff NP; Goosen C; Sahadat MC; Wolters EC; van Royen EA; Stoof JC
Synapse; 1994 Jun; 17(2):115-24. PubMed ID: 7916490
[TBL] [Abstract][Full Text] [Related]
5. In vivo measurement of haloperidol affinity to dopamine D2/D3 receptors by [123I]IBZM and single photon emission computed tomography.
Videbaek C; Toska K; Friberg L; Holm S; Angelo HR; Knudsen GM
J Cereb Blood Flow Metab; 2001 Jan; 21(1):92-7. PubMed ID: 11149673
[TBL] [Abstract][Full Text] [Related]
6. Comparison of intravenous and intraperitoneal [123I]IBZM injection for dopamine D2 receptor imaging in mice.
Meyer PT; Salber D; Schiefer J; Cremer M; Schaefer WM; Kosinski CM; Langen KJ
Nucl Med Biol; 2008 Jul; 35(5):543-8. PubMed ID: 18589298
[TBL] [Abstract][Full Text] [Related]
7. Iodine-123-iodobenzamide SPECT assessment of dopamine D2 receptor occupancy in riperidone-treated schizophrenic patients.
Dresel S; Tatsch K; Dähne I; Mager T; Scherer J; Hahn K
J Nucl Med; 1998 Jul; 39(7):1138-42. PubMed ID: 9669383
[TBL] [Abstract][Full Text] [Related]
8. [123I]IBZM SPECT in patients treated with typical and atypical neuroleptics: relationship to drug plasma levels and extrapyramidal side effects.
Schlösser R; Schlegel S; Hiemke C; Nickel O; Bockisch A; Rao ML; Hahn K
Psychiatry Res; 1997 Sep; 75(2):103-14. PubMed ID: 9351492
[TBL] [Abstract][Full Text] [Related]
9. [Dopamine (D2) receptor SPECT with 123I-iodobenzamide (IBZM) in diagnosis of Parkinson syndrome].
Reiche W; Grundmann M; Huber G
Radiologe; 1995 Nov; 35(11):838-43. PubMed ID: 8657887
[TBL] [Abstract][Full Text] [Related]
10. [In vivo characteristics of IBZM in rat brains: an agent for quantitative SPECT imaging of dopamine D2 receptors. Preparation of 125I-IBZM and its biodistribution and kinetic properties].
Matsumura K; Toyama H; Nakashima H; Ichise M; Kurami M; Nakagawa T; Maeda H; Takeuchi A; Koga S
Kaku Igaku; 1994 May; 31(5):513-9. PubMed ID: 8028224
[TBL] [Abstract][Full Text] [Related]
11. The discovery of epidepride and its analogs as high-affinity radioligands for imaging extrastriatal dopamine D(2) receptors in human brain.
de Paulis T
Curr Pharm Des; 2003; 9(8):673-96. PubMed ID: 12570798
[TBL] [Abstract][Full Text] [Related]
12. In-vivo SPECT imaging of D2 receptor with iodine-iodolisuride: results in supranuclear palsy.
Chabriat H; Levasseur M; Vidailhet M; Loc'h C; Mazière B; Bourguignon MH; Bonnet AM; Zilbovicius M; Raynaud C; Agid Y
J Nucl Med; 1992 Aug; 33(8):1481-5. PubMed ID: 1386104
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo D2-dopamine receptor binding with [123I]S(-) iodobenzamide ([123I]IBZM) in rat and human brain.
Verhoeff NP; Bobeldijk M; Feenstra MG; Boer GJ; Maas MA; Erdtsieck-Ernste E; de Bruin K; van Royen EA
Int J Rad Appl Instrum B; 1991; 18(8):837-46. PubMed ID: 1839302
[TBL] [Abstract][Full Text] [Related]
14. Initial experience with SPECT examinations using [123I]IBZM as a D2-dopamine receptor antagonist in Parkinson's disease.
Cordes M; Henkes H; Laudahn D; Bräu H; Kramp W; Girke W; Hierholzer J; Eichstädt H; Felix R
Eur J Radiol; 1991; 12(3):182-6. PubMed ID: 1830273
[TBL] [Abstract][Full Text] [Related]
15. Imaging of dopamine receptors with [123I]iodobenzamide single-photon emission-computed tomography in neuroleptic malignant syndrome.
Jauss M; Krack P; Franz M; Klett R; Bauer R; Gallhofer B; Dorndorf W
Mov Disord; 1996 Nov; 11(6):726-8. PubMed ID: 8914102
[TBL] [Abstract][Full Text] [Related]
16. Iodine-123-IBZM dopamine D2 receptor and technetium-99m-HMPAO brain perfusion SPECT in the evaluation of patients with and subjects at risk for Huntington's disease.
Ichise M; Toyama H; Fornazzari L; Ballinger JR; Kirsh JC
J Nucl Med; 1993 Aug; 34(8):1274-81. PubMed ID: 8326384
[TBL] [Abstract][Full Text] [Related]
17. Radioiodinated tracers for the evaluation of dopamine receptors in the neonatal rat brain after hypoxic-ischemic injury.
Zouakia A; Chalon S; Kung HF; Dognon AM; Saliba E; Besnard JC; Guilloteau D
Eur J Nucl Med; 1994 Jun; 21(6):488-92. PubMed ID: 8082661
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, in vitro binding profile and biodistribution of a 125I-labeled N-benzyl pyrrolidinyl benzamide derivative: a potential radioligand for mapping dopamine D2 receptors.
Saji H; Tanahashi K; Kinoshita T; Iida Y; Magata Y; Yokoyama A
Nucl Med Biol; 1996 Feb; 23(2):121-7. PubMed ID: 8868283
[TBL] [Abstract][Full Text] [Related]
19. SPECT tracer [(123)I]IBZM has similar affinity to dopamine D2 and D3 receptors.
Videbaek C; Toska K; Scheideler MA; Paulson OB; Moos Knudsen G
Synapse; 2000 Dec; 38(3):338-42. PubMed ID: 11020237
[TBL] [Abstract][Full Text] [Related]
20. [In vivo characteristics of IBZM in rat brains: an agent for quantitative SPECT imaging of D2 dopamine receptors--a basis for semiquantitative measurement of the receptor density using equilibrium analysis].
Toyama H; Matsumura K; Nakashima H; Ichise M; Kurami M; Nakagawa T; Maeda H; Takeuchi A; Koga S
Kaku Igaku; 1994 Sep; 31(9):1117-20. PubMed ID: 7967197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
